(Q39498368)

12 September 2017

1 reference

title

Neuropeptides, behavior, and aging (English)

1 reference

12 September 2017

Morley JE

1

1 reference

PubMed ID

3001165

12 September 2017

language of work or name

English

0 references

publication date

1 January 1986

1 reference

Journal of the American Geriatrics Society

12 September 2017

1 reference

12 September 2017

34

1 reference

12 September 2017

1

1 reference

12 September 2017

52-62

1 reference

Discovery of modification of the synthetic tripeptide-sequence of the thyrotropin releasing hormone having activity.

12 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Thyrotropin-releasing hormone in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

The effects of thyrotropin releasing hormone (TRH) on the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Thyrotrophin-releasing hormone inhibits the pentagastrin stimulated gastric secretion in man. A dose response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Extrahypothalamic Thyrotropin Releasing Hormone (TRH) — Its distribution and its functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Changes of beta-endorphin and Met-enkephalin content in the hypothalamus-pituitary axis induced by aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Morphine analgesia in mice of different ages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Ageing, opioid analgesia and the pineal gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Daily rhythms of analgesia in mice: effects of age and photoperiod

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Influence of age on pain relief from analgesics. A study of postoperative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

VARIATIONS IN CUTANEOUS AND VISCERAL PAIN SENSITIVITY IN NORMAL SUBJECTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Beta-endorphin and male sexual behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

The endocrinology of the opiates and opioid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Immunoreactive-β-endorphin and LHRH levels in the brains of aged male rats with impaired sex behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Neuropeptides are present in projection neurones at all levels in visceral and taste pathways: from periphery to sensory cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Flavor enhances the antidipsogenic effect of naloxone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

The neuroendocrine control of appetite: the role of the endogenous opiates, cholecystokinin, TRH, gamma-amino-butyric-acid and the diazepam receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

The pharmacology of eating behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Opioid modulation of appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Involvement of dynorphin and the kappa opioid receptor in feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

The effects of aging on opioid modulation of feeding in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

The influence of opiate agonists on day-night feeding rhythms in young and old mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Minireview. Stress induced eating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Avoidance learning at two levels of shock in rats receiving MSH1,2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Anti-amnesic effect of ACTH4–10: Its independence of the nature of the amnesic agent and the behavioral test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Effect of corticotropin and desglycinamide 9 -lysine vasopressin on suppression of memory by puromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Vasopressin and memory in Korsakoff syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Influence of vasopressin on learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

21 January 2018

Vasopressin in amnesia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Effects of vasopressin on human memory functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Vasopressor receptor antagonist prevents behavioural effects of vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Neuropeptides, mental performance and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Behavioral and Electrographic Changes in Rat and Man after MSH

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Possible significance of ACTH fragments for human mental performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Neuropeptides. A new dimension in biological psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

ACTH 4-10 in the amelioration of neuropsychological symptomatology associated with senile organic brain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

21 January 2018

Endogenous opiates: 1983

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Effect of ACTH, epinephrine, beta-endorphin, naloxone, and of the combination of naloxone or beta-endorphin with ACTH or epinephrine on memory consolidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Facilitation of hot-plate response learning by pre- and posttraining naltrexone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Opiate antagonists improve spatial memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

High-dose naloxone affects task performance in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Chemical Anatomy of the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Effects of naloxone in senile dementia: a double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Decreased level of β-endorphin-like immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Thyrotropin releasing hormone content is unchanged in brains of patients with Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Dynorphin-(1–13), dopamine and feeding in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

The ascent of cholecystokinin (CCK) — From gut to brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Somatostatin and dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Huntington's disease: New approaches to an old problem: The Robert Wartenberg Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Reduced glutamic-acid-decarboxylase activity of post-mortem brain in Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Human brain substance P: distribution in controls and Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Reduction in cholecystokinin-like immunoreactivity in the basal ganglia in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Cholecystokinin receptors are decreased in basal ganglia and cerebral cortex of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Regional Brain Concentrations of Neuropeptides in Huntington's Chorea and Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Somatostatin is increased in the basal ganglia in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Brain immunoreactive gonadotropin-releasing hormone in Huntington's chorea and in non-choreic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

The rigid form of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Some Observations on the Opiate Peptides and Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Intravenous Naloxone Administration in Schizophrenia and Affective Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Indication of an Antipsychotic Action of the Opiate Antagonist Naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Effects of Naloxone on Schizophrenia: Reduction in Hallucinations in a Subpopulation of Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Improvement of Schizophrenic Patients Treated With Des-Tyr1]-γ-endorphin (DTγE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Plasma β-Endorphin Immunoreactivity in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Peptides, the limbic lobe and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Dexamethasone suppression test and serum prolactin in dementia disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Cortisol response to vasopressin in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

CSF β-endorphin-immunoreactivity in normal, schiziphrenic, depressed, manic and anorexic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Peptides in the cerebrospinal fluid of neuropsychiatric patients: An approach to central nervous system peptide function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB06340.X

10.1111/J.1532-5415.1986.TB06340.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference

PubMed ID

3001165